> Still awaiting federal approval, botox-maker Allergan has extended its exchange offer for Inamed shares from tomorrow to February 22. Report
> Mylan Pharmaceuticals has received an FDA nod to make a generic version of McNeil PPC's Flexeril muscle relaxant. Report
> India's Biocon has made a $3.5 million bid for the intellectual property of Nobex IP. Nobex, which is in bankruptcy, plans to auction its assets March 16. Report
> Chutes & Ladders: GlaxoSmithKline has named Moncef Slaoui as its new R&D chief. Report
> India's Sun Pharmaceuticals plans to spin off its R&D division into a new company. Report
> India's Ranbaxy has set up a joint venture with a South African company to market its generic AIDS drug. Report
> San Diego-based Metabasis Therapeutics has filed a shelf registration to sell up to $75 million in common shares. Release
> AnGes and Seikagaku jointly announced on February 3 that they have agreed to dissolve their agreement on joint development of NF-kappa B decoy oligodeoxynucleotide. Release
> MediciNova has completed enrollment of 297 patients with relapsing MS in its Phase II trial of MN-166. Release
And Finally...Two aging brothers demonstrate that discipline and diet can play a major role in fighting diabetes. Article